IL107776A0 - Injectable compositions containing taxol and methods for the preparation thereof - Google Patents

Injectable compositions containing taxol and methods for the preparation thereof

Info

Publication number
IL107776A0
IL107776A0 IL10777693A IL10777693A IL107776A0 IL 107776 A0 IL107776 A0 IL 107776A0 IL 10777693 A IL10777693 A IL 10777693A IL 10777693 A IL10777693 A IL 10777693A IL 107776 A0 IL107776 A0 IL 107776A0
Authority
IL
Israel
Prior art keywords
preparation
methods
compositions containing
injectable compositions
containing taxol
Prior art date
Application number
IL10777693A
Other languages
English (en)
Original Assignee
Napro Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napro Biotherapeutics Inc filed Critical Napro Biotherapeutics Inc
Publication of IL107776A0 publication Critical patent/IL107776A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10777693A 1992-11-27 1993-11-26 Injectable compositions containing taxol and methods for the preparation thereof IL107776A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPL607492 1992-11-27

Publications (1)

Publication Number Publication Date
IL107776A0 true IL107776A0 (en) 1994-02-27

Family

ID=3776561

Family Applications (2)

Application Number Title Priority Date Filing Date
IL10777693A IL107776A0 (en) 1992-11-27 1993-11-26 Injectable compositions containing taxol and methods for the preparation thereof
IL12617898A IL126178A0 (en) 1992-11-27 1998-09-10 Methods for stabilizing compositions containing taxol and pharmaceutical compositions containing taxol prepared

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL12617898A IL126178A0 (en) 1992-11-27 1998-09-10 Methods for stabilizing compositions containing taxol and pharmaceutical compositions containing taxol prepared

Country Status (8)

Country Link
KR (1) KR100371062B1 (xx)
CN (2) CN1096673A (xx)
AU (1) AU5553894A (xx)
IL (2) IL107776A0 (xx)
IN (1) IN176188B (xx)
NZ (1) NZ258044A (xx)
WO (1) WO1994012198A1 (xx)
ZA (1) ZA938844B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2149150C (en) * 1992-11-27 2000-08-01 David R. Carver Injectable taxol composition with improved stability
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
FR2710534B1 (fr) * 1994-09-28 1996-07-05 Bristol Myers Squibb Co Solvant de stabilisation, composition pharmaceutique le contenant, et son procédé de préparation.
NL9500340A (nl) * 1995-02-22 1996-10-01 Yew Tree Pharmaceuticals B V Gestabiliseerde paclitaxel-oplossing en farmaceutisch preparaat dat deze oplossing bevat.
US5686488A (en) * 1995-08-25 1997-11-11 Alcon Laboratories, Inc. Polyethoxylated castor oil products as anti-inflammatory agents
DE19536165A1 (de) * 1995-09-28 1997-04-03 Basf Ag Verfahren zur Reinigung von alkoxylierten Fetten
CA2240595A1 (en) * 1995-12-21 1997-07-03 Bijan Almassian Taxane composition and method
KR100191446B1 (ko) * 1996-05-02 1999-06-15 송영욱 파클리탁셀 함유 전신성 홍반성 낭창치료제
KR100330373B1 (ko) * 1996-05-28 2002-11-07 주식회사한국신약 탁솔을 함유한 주사용 약제 조성물
KR100358934B1 (ko) * 1996-09-13 2003-01-29 주식회사한국신약 탁솔을함유한주사용약제조성물
US6045808A (en) * 1997-01-31 2000-04-04 Pharmacia & Upjohn Company Method for removing high boiling solvents from drug formulations by vacuum drying
CN1101677C (zh) * 1997-05-30 2003-02-19 韩万愚 含有紫杉醇的药用注射溶液
ATE226070T1 (de) * 1997-05-30 2002-11-15 Man Woo Han Taxol enthaltende pharmazeutische injektionslösung
BE1011216A3 (fr) * 1997-06-13 1999-06-01 Thissen En Abrege L T B Lab Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition.
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
WO2002043765A2 (en) 2000-11-28 2002-06-06 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
DE10115740A1 (de) * 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
KR100774366B1 (ko) 2001-09-10 2007-11-08 주식회사 중외제약 파클리탁셀 주사제 조성물
CZ294371B6 (cs) * 2002-06-10 2004-12-15 Pliva - Lachema, A. S. Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
ES2611054T3 (es) * 2002-06-26 2017-05-04 Syncore Biotechnology Co., Ltd Método para producir una preparación de liposomas catiónicos que comprende un compuesto lipófilo
JP2008543789A (ja) * 2005-06-17 2008-12-04 ホスピラ オーストラリア ピーティーワイ エルティーディー ドセタキセルの液体薬学的処方物
SI1931321T1 (sl) 2005-08-31 2019-07-31 Abraxis Bioscience, Llc Sestave, ki zajemajo slabo vodotopne farmacevtske učinkovine in antimikrobna sredstva
CN101396354B (zh) * 2007-09-30 2010-12-01 江苏恒瑞医药股份有限公司 一种稳定的塔三烷类化合物液体组合物及其制备方法和其应用
CN101829051B (zh) * 2010-05-31 2012-09-12 南昌弘益科技有限公司 1’-乙酰氧基胡椒酚乙酸酯注射液
CN103432109B (zh) * 2013-09-01 2015-09-23 吴静 紫杉醇的药物组合物
US10561766B2 (en) * 2015-09-15 2020-02-18 W. L. Gore & Associates, Inc. Drug composition and coating

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5157049A (en) * 1988-03-07 1992-10-20 The United States Of America As Represented By The Department Of Health & Human Services Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
TW223634B (xx) * 1991-03-18 1994-05-11 Kingston David G I
DE69229267T2 (de) * 1991-04-19 1999-12-16 Univ Mississippi University Verfahren und zubereitungen zur isolierung von taxanen

Also Published As

Publication number Publication date
NZ258044A (en) 1995-12-21
AU5553894A (en) 1994-06-22
WO1994012198A1 (en) 1994-06-09
CN1095266A (zh) 1994-11-23
IL126178A0 (en) 1999-05-09
ZA938844B (en) 1994-08-02
CN1096673A (zh) 1994-12-28
AU667142B2 (en) 1996-03-07
IN176188B (xx) 1996-02-24
KR100371062B1 (ko) 2003-04-21
AU5196793A (en) 1994-06-09
CN1047305C (zh) 1999-12-15

Similar Documents

Publication Publication Date Title
IL107776A0 (en) Injectable compositions containing taxol and methods for the preparation thereof
ZA937321B (en) Taxol derivatives their preparation and compositions containing them
IL106431A0 (en) Aminediol derivatives and pharmaceutical compositions containing the same
IL108873A0 (en) 2-debenzoyl-2-acyl taxol derivatives, pharmaceutical compositions containing the same, and methods for the preparation thereof
IL104107A0 (en) New compounds and compositions
NZ244766A (en) Bi-aromatic compounds and pharmaceutical compositions
IL110376A0 (en) Pharmaceutical compositions containing ifetroban and methods for the preparation thereof
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
GB9319500D0 (en) Pharmaceutical composition
GB2272375B (en) Pharmaceutical composition
HK1007551A1 (en) Basic aluminium antiperspirant active materials antiperspirant active compositions comprising the same and method for the preparation thereof
EP0587047A3 (en) Gestagenes containing pharmaceutical composition
SG27894G (en) Injectable compositions containing 25-cyclohexyl-avermectin B1
ZA937592B (en) Pharmaceutical composition
GB9220143D0 (en) Compounds and compositions
ZA935078B (en) Pharmaceutical composition
ZA94155B (en) Pharmaceutical composition
GB9220088D0 (en) Compounds and compositions
ZA935931B (en) Pharmaceutical composition
ZA924061B (en) Pharmaceutical composition
ZA931984B (en) Pharmaceutical composition
IL103091A0 (en) Taste-making pharmaceutical compositions and methods for making the same
ZA93245B (en) Pharmaceutical bacteriocin compositions and methods for using the same
HU9803012D0 (en) N-cycloalkyl-amine-derivatives and pharmaceutical compositions containing the same
IL97708A0 (en) Pharmaceutical compositions containing piperidinyl-benzocycloheptathiophenone derivatives and methods for the use thereof

Legal Events

Date Code Title Description
FF Patent granted
KB20 Patent renewed for 20 years
EXP Patent expired